Skip to main content
PLOS One logoLink to PLOS One
. 2023 Dec 20;18(12):e0296372. doi: 10.1371/journal.pone.0296372

Correction: Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice

The PLOS ONE Staff
PMCID: PMC10732422  PMID: 38117773

Notice of Republication

An incorrect version of S2 Figure was published and the publisher apologizes for this error. This article was republished on December 11, 2023 to correct this error. Please download this article again to view the correct version.Reference

Reference

  • 1.Bosman M, Krüger DN, Favere K, De Meyer GRY, Franssen C, Van Craenenbroeck EM, et al. (2023) Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice. PLoS ONE 18(11): e0294848. 10.1371/journal.pone.0294848 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES